The results showed a greater accumulation of early‐Tex in tumor tissues with pathological complete response to neoCRT (Figure 2l–n), suggesting that NR1D2+ Tex is associated with better clinical outcomes in LARC. This evidence concerns the gene NR1D2 and neoplasm.